ARDT (Ardent Health, Inc.) Stock Analysis - Community

Ardent Health, Inc. (ARDT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDT trades at $9.45 with a market cap of $1.45B and a P/E ratio of 9.87. ARDT moved -3.57% today. Year to date, ARDT is +5.70%; over the trailing twelve months it is -37.54%. Its 52-week range spans $8.07 to $20.72. Analyst consensus is buy with an average price target of $12.59. Rallies surfaces ARDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade ARDT?

Rallies community data for ARDT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

ARDT Key Metrics

Key financial metrics for ARDT
MetricValue
Price$9.45
Market Cap$1.45B
P/E Ratio9.87
EPS$0.96
Dividend Yield0.00%
52-Week High$20.72
52-Week Low$8.07
Volume10
Avg Volume0
Revenue (TTM)$6.32B
Net Income$230.13M
Gross Margin0.00%

Latest ARDT News

Recent ARDT Insider Trades

  • Webb Robert Thomas bought 10.00K (~$174.70K) on Nov 8, 2024.
  • Webb Robert Thomas bought 10.00K (~$164.90K) on Nov 8, 2024.

ARDT Analyst Consensus

10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.59.

Common questions about ARDT

How does the Rallies community trade ARDT?
Rallies community data for ARDT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for ARDT?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for ARDT when enough community data is available.
Is ARDT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARDT. It does not provide personalized investment advice.
ARDT

ARDT